September 30, 2015—The Health Resources and Services Administration’s proposed 340B mega-guidance is an “encouraging first step” toward reform, says the drug-industry-led group AIR 340B in a new communiqué.
You must be registered to read complete articles (it's quick, easy, and 100% free). Click here to register. Already registered? Click here to login. (340B Health members, Drug Discount Monitor subscribers, and 340B Coalition conference attendees: Use your existing username and password.)